tiprankstipranks
Lifeloc Technologies Inc (LCTC)
OTHER OTC:LCTC
US Market
Want to see LCTC full AI Analyst Report?

Lifeloc Technologies (LCTC) AI Stock Analysis

13 Followers

Top Page

LCTC

Lifeloc Technologies

(OTC:LCTC)

Select Model
Select Model
Select Model
Neutral 59 (OpenAI - Gpt-5.6Sol)
Rating:59Neutral
Price Target:
$4.00
▲(3.36% Upside)
Action:Reiterated
Date:08/18/26
The score is driven primarily by mixed financial performance: strong revenue rebound, improved margins, low leverage, and recently positive free cash flow are encouraging, but ongoing losses and uneven earnings quality cap the rating. Technicals are notably strong with price above all major moving averages and positive MACD, while valuation remains pressured due to negative earnings and no dividend support. Corporate updates add a positive tilt via SpinDetect commercialization progress and shareholder backing.
Positive Factors
Revenue rebound and improved gross margin
The sharp top-line rebound, alongside improved gross margin, indicates renewed demand and better unit economics. If maintained, this gives Lifeloc more internal capacity to fund product development and absorb operating costs.
Negative Factors
Persistent unprofitability
Revenue recovery has not yet translated into sustainable earnings. Continued net, EBIT, and EBITDA losses constrain internally generated capital, increase execution pressure, and leave the company reliant on operating improvement to support long-term growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue rebound and improved gross margin
The sharp top-line rebound, alongside improved gross margin, indicates renewed demand and better unit economics. If maintained, this gives Lifeloc more internal capacity to fund product development and absorb operating costs.
Read all positive factors

Lifeloc Technologies (LCTC) vs. SPDR S&P 500 ETF (SPY)

Lifeloc Technologies Business Overview & Revenue Model

Company Description
Lifeloc Technologies, Inc. develops, manufactures, and markets portable hand-held and fixed station breathalyzers and related accessories for law enforcement, workplace, corrections, original equipment manufacturing, and consumer markets worldwide...
How the Company Makes Money
Lifeloc primarily makes money by selling breath alcohol testing devices (breathalyzers) to institutional and individual customers. Revenue is also generated from recurring and ancillary sales tied to the installed base of devices, including replac...

Lifeloc Technologies Financial Statement Overview

Summary
Mixed fundamentals. Revenue rebounded sharply (+249% TTM) and gross margin improved (~42%), with a de-risked balance sheet (very low debt-to-equity ~0.03) and positive TTM operating/free cash flow (~$0.47M/~$0.56M). Offsetting this, profitability remains weak with negative net margin (~-22%) and negative EBIT/EBITDA, and cash flow has been volatile historically.
Income Statement
38
Negative
Balance Sheet
66
Positive
Cash Flow
55
Neutral
BreakdownTTMDec 2025Dec 2024Mar 2024Dec 2022Dec 2021
Income Statement
Total Revenue9.27M9.03M8.54M9.33M8.48M7.05M
Gross Profit3.89M3.64M3.45M4.04M3.07M3.06M
EBITDA-463.08K-786.57K-1.07M139.45K98.46K937.83K
Net Income-2.07M-2.47M-1.05M205.61K-455.76K675.97K
Balance Sheet
Total Assets7.08M6.69M8.72M8.69M8.52M8.95M
Cash, Cash Equivalents and Short-Term Investments908.21K746.00K1.24M1.77M2.35M2.57M
Total Debt2.28M1.83M1.80M1.22M1.27M1.32M
Total Liabilities3.26M2.58M2.50M2.33M2.36M2.36M
Stockholders Equity3.82M4.10M6.23M6.36M6.16M6.59M
Cash Flow
Free Cash Flow562.84K-460.77K-2.02M-533.96K-168.25K-85.53K
Operating Cash Flow472.75K2.02K-1.33M-525.74K54.33K182.94K
Investing Cash Flow-112.13K-354.38K-689.45K-8.21K-222.58K-268.48K
Financing Cash Flow416.69K355.95K1.49M-52.18K-50.66K462.13K

Lifeloc Technologies Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3.87
Price Trends
50DMA
3.52
Positive
100DMA
2.77
Positive
200DMA
2.60
Positive
Market Momentum
MACD
0.11
Positive
RSI
54.39
Neutral
STOCH
49.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LCTC, the sentiment is Positive. The current price of 3.87 is below the 20-day moving average (MA) of 3.90, above the 50-day MA of 3.52, and above the 200-day MA of 2.60, indicating a neutral trend. The MACD of 0.11 indicates Positive momentum. The RSI at 54.39 is Neutral, neither overbought nor oversold. The STOCH value of 49.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for LCTC.

Lifeloc Technologies Risk Analysis

Lifeloc Technologies disclosed 36 risk factors in its most recent earnings report. Lifeloc Technologies reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Lifeloc Technologies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
59
Neutral
$10.65M-5.44-21.03%9.13%-75.10%
56
Neutral
$81.45M-66.67-10.92%7.85%45.80%
47
Neutral
$74.84M852.170.15%25.56%
44
Neutral
$16.74M-7.35-159.17%-46.47%-26.00%
44
Neutral
$123.57M-1.20-92.81%28.49%-296.38%
40
Underperform
$2.65M-0.09-171.94%17.67%92.17%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
LCTC
Lifeloc Technologies
3.88
0.60
18.14%
REFR
Research Frontiers
0.49
-0.99
-67.01%
CPSH
CPS Technologies
3.92
0.47
13.62%
LINK
Interlink Electronics
5.20
-0.41
-7.31%
SOBR
SOBR Safe
0.47
-2.89
-85.95%
KULR
KULR Technology Group
2.66
-2.20
-45.27%

Lifeloc Technologies Corporate Events

Business Operations and StrategyProduct-Related Announcements
Lifeloc Advances SpinDetect Toward Scalable THC Test Commercialization
Positive
Jun 16, 2026
On June 15, 2026, Lifeloc Technologies announced it has completed production tooling for its SpinDetect consumable test disks, produced and tested first-article units, and finished minor mold modifications, enabling new disks for ongoing validatio...
Business Operations and StrategyExecutive/Board ChangesShareholder Meetings
Lifeloc Shareholders Back Leadership, Governance Changes at Meeting
Positive
Jun 5, 2026
At its June 3, 2026 Annual Meeting of Shareholders, Lifeloc Technologies reported that 82.7% of its 2,752,616 outstanding common shares were represented, establishing a solid quorum and indicating strong shareholder engagement in its corporate gov...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 18, 2026